Mammography utilization, public health impact, and cost-effectiveness in the United States.
Mammography utilization, public health impact, and cost-effectiveness in the United States.
复制标题
美国乳腺 X 光检查的利用、公共卫生影响和成本效益。
DOI：
10.1146/annurev.pu.14.050193.003133
复制
发表时间：
1993
影响因子：
20.8
通讯作者：
Taylor,V
中科院分区：
文献类型：
--
作者：
White,E;Urban,N;Taylor,V
乳腺癌是美国的一个主要健康问题：1991 年估计有 175,000 名女性被诊断患有乳腺癌，45,000 人死于该病 (2)。在女性中，乳腺癌是最常见的癌症，只有肺癌导致更多的癌症死亡。按 1984 年美元计算，治疗一例乳腺癌的终生费用估计为 37,000 美元 (8)，相当于 1991 年美元的 61,000 美元，这表明 1991 年乳腺癌给社会造成的损失超过 100 亿美元。这些只是医疗保健系统承担的美元成本，不包括妇女及其家人承受的疼痛、焦虑和痛苦的费用。最近，美国审计总署向美国国会提交了一份报告，回顾了 20 年来乳腺癌预防、诊断和治疗的进展（79）。该报告的结论是，在这三个领域的进展中，减少乳腺癌死亡人数的最佳前景是增加乳房X光检查的使用。该建议基于对照研究，这些研究表明，对无症状女性进行乳腺癌筛查可以大大减少该疾病的死亡人数。
Breast cancer is a major health problem in the United States: An estimated 175,000 women were diagnosed with breast cancer in 1991, and 45,000 died from the disease (2). Among women, breast cancer is the most common form of cancer, and only lung cancer causes more cancer deaths. The lifetime cost of treating a case of breast cancer was estimated to be $37,000 in 1984 dollars (8), equivalent to $61,000 in 1991 dollars, which suggests that breast cancer cost society over $10 billion in 1991. These are only the dollar costs borne by the medical care system, exclusive of the costs of pain, anxiety, and suffering borne by the women and their families. Recently, the General Accounting Office presented to the US Congress a report reviewing 20 years of progress in the prevention, diagnosis, and treatment of breast cancer (79). The report concluded that, among the advances in these three areas, the best prospect for reducing the number of deaths from breast cancer is increased utilization of screening mammography. This recommendation was based on controlled studies that have demonstrated that screening asymptomatic women for breast cancer can substantially reduce deaths from the disease.